Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry
No Thumbnail Available
If you need an accessible version of this item, please email your request to iusw@iu.edu so that they may create one and provide it to you.
Date
2014-07-23
Journal Title
Journal ISSN
Volume Title
Publisher
Scienctific Reports
Permanent Link
Abstract
A robust top down proteomics method is presented for profiling alpha-synuclein species from autopsied human frontal cortex brain tissue from Parkinson's cases and controls. The method was used to test the hypothesis that pathology associated brain tissue will have a different profile of post-translationally modified alpha-synuclein than the control samples. Validation of the sample processing steps, mass spectrometry based measurements, and data processing steps were performed. The intact protein quantitation method features extraction and integration of m/z data from each charge state of a detected alpha-synuclein species and fitting of the data to a simple linear model which accounts for concentration and charge state variability. The quantitation method was validated with serial dilutions of intact protein standards. Using the method on the human brain samples, several previously unreported modifications in alpha-synuclein were identified. Low levels of phosphorylated alpha synuclein were detected in brain tissue fractions enriched for Lewy body pathology and were marginally significant between PD cases and controls (p = 0.03).
Description
Keywords
Proteomic analysis, Mass spectrometry, Diagnostic markers, Parkinson's disease
Citation
Sci Rep. 2014 Jul 23;4:5797
DOI
Link(s) to data and video for this item
Rights
Type
Dataset